Cart summary

You have no items in your shopping cart.

KRCA-0008

SKU: orb1226209

Description

KRCA-0008 is a potent, selective ALK inhibitor with IC50 of 12 nM (wt ALK), also is potent against various ALK mutants, including L1196M, F1174L, R1275Q, and C1156Y (IC50=5-75 nM); weakly inhibits IR (IC50=210 nM), inhibits H3122 and BaF3 EML4-ALK L1196M cell proliferation with IC50 of 80 and 68 nM, respectively; demonstrates in vivo efficacy comparable to Crizotinib in xenograft mice model, has drug-like properties without hERG concerns.

Images & Validation

Key Properties

CAS Number1472795-20-2
MW609.119
Purity>98% (HPLC)
FormulaC30H37ClN8O4
SMILESClC1=CN=C(NC2=CC=C(N3CCN(C(C)=O)CC3)C=C2OC)N=C1NC4=CC=C(N5CCN(C(C)=O)CC5)C=C4OC
TargetALK
Solubility10 mM in DMSO

Bioactivity

In Vivo
Animal model: NOD/SCID mice with Karpas-299 xenografts. Dosage: 25 and 50 mg/kg. Administration: Oral gavage; 25 and 50 mg/kg twice a day; for two weeks. Result: Significantly inhibited tumor growth by inhibiting NPM-ALK phosphorylation without showing overt signs of toxicity or significant compound-related body weight loss.
In Vitro
Cell Proliferation Assay Cell line: H3122 and H1993 cell lines. Concentration: 200 nM. Incubation time: 6 hours. Result: Inhibited cell proliferation of H3122 and H1993 cells with IC50s of 0.08 and 3.6 nM, respectively. Cell Proliferation Assay Cell line: NPM-ALK-positive ALCL cell lines (Karpas-299 and SU-DHL-1) and U937 NPM ALK-negative lymphoma cell line. Concentration: 200 nM. Incubation time: 72 hours. Result: Inhibited proliferation of Karpas-299, SU-DHL-1 and U937 cells with GI50s of 12 nM, 3 nM and 3.5 μM, respectively. Western blot analysis. Cell line: Karpas-299 and SU-DHL-1 cell lines. Concentration: 0, 10, 100 and 1000 nM. Incubation time: 4 hours. Result: Completely suppressed phosphorylation of ALK and its effectors at a dose of 100 nM in NPM-ALK-positive ALCL cells. Apoptosis Analysis Cell line: SU-DHL-1 cell line. Concentration: 0-1 μM. Incubation time: 72 hours. Result: Dose-dependently increased cspase-3/7 activities and induced cell apoptosis. Cell Cycle Analysis Cell line: Karpas-299 and SU-DHL-1 cell lines. Concentration: 0-100 nM. Incubation time: 48 hours. Result: Induced G0/G1 cell cycle arrest in ALCL cells expressing NPM-ALK.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

KRCA 0008 | KRCA0008

Similar Products

  • KRCA-0008 [orb1305226]

    96.19%

    1472795-20-2

    609.12

    C30H37ClN8O4

    5 mg, 10 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO), 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

KRCA-0008 (orb1226209)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 80.00
10 mg
$ 120.00
25 mg
$ 200.00
50 mg
$ 360.00
100 mg
$ 580.00